文献速递睡眠呼吸障碍

阻塞性睡眠呼吸暂停治疗对心脑血管合并症的影响:一项长期全国性队列研究

OSA Treatment on Cardio- and Cerebrovascular Comorbidities: A Long-term Nationwide Cohort Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-12-14

基于台湾全民健康保险研究数据库的回顾性队列研究,纳入2001年1月至2013年12月确诊的成人阻塞性睡眠呼吸暂停患者,比较上气道手术与持续气道正压通气(CPAP)治疗后的心脑血管结局。中位13年随访显示,手术组与CPAP组在心肌梗死和卒中风险上无显著差异。

要点

  • 上气道手术与CPAP治疗组的心肌梗死风险无显著差异(HR 1.03,95%CI 0.781-1.359)。
  • 上气道手术与CPAP治疗组的卒中风险无显著差异(HR 1.12,95%CI 0.736-1.706)。
  • 随访期间手术组心肌梗死发生率327/10万人年,CPAP组298/10万人年。

核心结论

  • 在13年随访中,阻塞性睡眠呼吸暂停患者接受CPAP或手术治疗后的心脑血管结局无差异。

研究设计与样本

  • 回顾性队列研究,基于台湾全民健康保险研究数据库,分析2001年1月至2013年12月所有年龄>20岁且经ICD-9-CM确诊的阻塞性睡眠呼吸暂停成人病例。
  • 将接受上气道手术的阻塞性睡眠呼吸暂停患者与按年龄、性别和合并症指数匹配的接受CPAP治疗的对照进行比较。

主要发现

  • 随访期间,手术组和CPAP组分别发生112例和92例新发心肌梗死(发生率分别为327/10万人年和298/10万人年)。
  • 手术组和CPAP组分别新诊断50例和39例卒中(发生率分别为144/10万人年和125/10万人年)。
  • Cox比例风险回归显示,调整性别、索引日期年龄、诊断至治疗天数及合并症后,手术组与CPAP组相比心肌梗死风险无显著差异(HR 1.03,95%CI 0.781-1.359;P=0.833)。
  • Cox比例风险回归显示,调整相同协变量后,手术组与CPAP组相比卒中风险无显著差异(HR 1.12,95%CI 0.736-1.706;P=0.596)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the cardio- and cerebrovascular outcomes and survival rates of surgical and nonsurgical interventions for patients with obstructive sleep apnea (OSA) based on a national population-based database. STUDY DESIGN: Retrospective cohort study. SETTING: Taiwan National Health Insurance Research Database. METHODS: We analyzed all cases of OSA among adults (age >20 years and confirmed with ICD-9-CM) from January 2001 to December 2013. We compared the patients with OSA who received upper airway surgery with age-, sex-, and comorbidity index-matched controls with continuous positive airway pressure (CPAP) treatment. The risk of myocardial infarction (MI) or stroke after treatment of OSA-related surgery versus CPAP was investigated. RESULTS: During follow-up, 112 and 92 incident cases of MI occurred in the OSA surgery and CPAP treatment groups, respectively (rates of 327 and 298 per 100,000 person-years). Furthermore, 50 and 39 cases were newly diagnosed with stroke in the OSA surgery and CPAP treatment groups (rates of 144 and 125 per 100,000 person-years). Cox proportional hazard regressions showed that the OSA treatment groups (OSA surgery vs CPAP) were not significantly related to MI (hazard ratio, 1.03 [95% CI, 0.781-1.359]; P = .833) and stroke (hazard ratio, 1.12 [95% CI, 0.736-1.706]; P = .596) at follow-up, after adjustment for sex, age at index date, days from diagnosis to treatment, and comorbidities. CONCLUSION: Our study demonstrated that there was no difference of cardio- and cerebrovascular results between CPAP and surgery for patients with OSA in a 13-year follow-up. LEVEL OF EVIDENCE: 3.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Yang KL, Lin PW, Chang CT, et al. OSA Treatment on Cardio- and Cerebrovascular Comorbidities: A Long-term Nationwide Cohort Study. Otolaryngol Head Neck Surg. 2021. PMID: 34905426. doi:10.1177/01945998211065656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。